The dsRNA binding site of human toll-like receptor 3

被引:171
作者
Bell, Jessica K.
Askins, Janine
Hall, Pamela R.
Davies, David R.
Segal, David M.
机构
[1] NIDDKD, Mol Biol Lab, NIH, Bethesda, MD 20892 USA
[2] NCI, Expt Immunol Branch, NIH, Bethesda, MD 20892 USA
关键词
double-stranded RNA; innate immunity; leucine-rich repeat;
D O I
10.1073/pnas.0603245103
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Pathogen recognition by Toll-like receptors (TLRs) initiates innate immune responses that are essential for inhibiting pathogen dissemination and for the development of acquired immunity. The TLRs recognize pathogens with their N-terminal ectodomains (ECD), but the molecular basis for this recognition is not known. Recently we reported the x-ray structure for unliganded TLR3-ECD; however, it has proven difficult to obtain a crystal structure of TLR3 with its ligand, dsRNA. We have now located the TLR3 ligand binding site by mutational analysis. More than 50 single-residue mutations have been generated throughout the TLR3-ECD, but only two, H539E and N541A, resulted in the loss of TLR3 activation and ligand binding functions. These mutations locate the dsRNA binding site on the glycan-free, lateral surface of TLR3 toward the C terminus and suggest a model for dsRNA binding and TLR3 activation.
引用
收藏
页码:8792 / 8797
页数:6
相关论文
共 50 条
  • [21] Glycogen synthase kinase 3β in Toll-like receptor signaling
    Ko, Ryeojin
    Lee, Soo Young
    BMB REPORTS, 2016, 49 (06) : 305 - 310
  • [22] Activation of Toll-Like Receptor 3 Augments Myofibroblast Differentiation
    Sugiura, Hisatoshi
    Ichikawa, Tonrohiro
    Koarai, Akira
    Yanagisawa, Satoru
    Minakata, Yoshiaki
    Matsunaga, Kazuto
    Hirano, Tsunahiko
    Akamatsu, Keiichiro
    Ichinose, Masakazu
    AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY, 2009, 40 (06) : 654 - 662
  • [23] Toll-like receptor 3 C1234T may protect against geographic atrophy through decreased dsRNA binding capacity
    Zhou, Peng
    Fan, Lei
    Yu, Ke-Da
    Zhao, Ming-Wei
    Li, Xiao-Xin
    FASEB JOURNAL, 2011, 25 (10) : 3489 - 3495
  • [24] Evidence of Toll-like receptor molecules on human platelets
    Cognasse, F
    Hamzeh, H
    Chavarin, P
    Acquart, S
    Genin, C
    Garraud, O
    IMMUNOLOGY AND CELL BIOLOGY, 2005, 83 (02) : 196 - 198
  • [25] Toll-like receptor polymorphisms and susceptibility to human disease
    Misch, E. Ann
    Hawn, Thomas R.
    CLINICAL SCIENCE, 2008, 114 (5-6) : 347 - 360
  • [26] Human endometrial epithelial cells cyclically express toll-like receptor 3 (TLR3) and exhibit TLR3-dependent responses to dsRNA
    Jorgenson, RL
    Young, SL
    Lesmeister, MJ
    Lyddon, TD
    Misfeldt, ML
    HUMAN IMMUNOLOGY, 2005, 66 (05) : 469 - 482
  • [27] Toll-like receptor 3 ligands for breast cancer therapies (Review)
    Butkowsky, Carly
    Aldor, Natalie
    Poynter, Sarah J.
    MOLECULAR AND CLINICAL ONCOLOGY, 2023, 19 (02)
  • [28] Toll-like receptor 3 expressed by melanoma cells as a target for therapy?
    Salaun, Bruno
    Lebecque, Serge
    Matikainen, Sampsa
    Rimoldi, Donata
    Romero, Pedro
    CLINICAL CANCER RESEARCH, 2007, 13 (15) : 4565 - 4574
  • [29] Targeting Toll-like receptor 3 in dendritic cells for cancer immunotherapy
    Matsumoto, Misako
    Takeda, Yohei
    Seya, Tsukasa
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2020, 20 (08) : 937 - 946
  • [30] Toll-Like Receptor 9 Agonists in Cancer
    Karapetyan, Lilit
    Luke, Jason J.
    Davar, Diwakar
    ONCOTARGETS AND THERAPY, 2020, 13 : 10039 - 10060